Cargando…

1767. Structured Treatment Interruptions in HIV-Infected Patients Receiving Antiretroviral Therapy—Implications for Future HIV Cure Trials: A Systematic Review and Meta-analysis

BACKGROUND: Safety and tolerability of analytical treatment interruption (TI) as part of HIV cure studies has been discussed controversially. In this systematic review and meta-analysis, we report current evidence for the occurrence of adverse effects during different types of TI. METHODS: A systema...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stecher, Melanie, Löhnert, Annika Y, Klein, Florian, Lehmann, Clara, Wyen, Christoph, Fätkenheuer, Gerd, Vehreschild, Janne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252569/ http://dx.doi.org/10.1093/ofid/ofy209.152

Ejemplares similares

1280. Geospatial Spread of HIV in the Cologne-Bonn Region, Germany: From 2001 to 2016
por: Stecher, Melanie, et al.
Publicado: (2018)

1283. Pretreatment HIV-1 Drug Resistance in Transmission Clusters of the Cologne-Bonn Region, Germany
por: Stecher, Melanie, et al.
Publicado: (2018)

Interrupting antiretroviral treatment in HIV cure research: scientific and ethical considerations
por: Garner, Samual A, et al.
Publicado: (2017)

Unwillingness of patients in Ghana to interrupt antiretroviral therapy for HIV cure research
por: Bonney, Evelyn Y., et al.
Publicado: (2021)

Molecular Epidemiology of the HIV Epidemic in Three German Metropolitan Regions – Cologne/Bonn, Munich and Hannover, 1999–2016
por: Stecher, Melanie, et al.
Publicado: (2018)

1269. Cohort Profile: The Translational Platform HIV (TP-HIV), a Multicenter Cohort Project in Germany
por: Stecher, Melanie, et al.
Publicado: (2019)

Optimizing Antiretroviral Therapy in Heavily ART-Experienced Patients with Multi-Class Resistant HIV-1 Using Proviral DNA Genotypic Resistance Testing
por: Rauschning, Dominic, et al.
Publicado: (2023)

HEnRY: a DZIF LIMS tool for the collection and documentation of biomaterials in multicentre studies
por: Heinen, Stephanie, et al.
Publicado: (2020)

Interrupting antiretroviral therapy in HIV cure trials during COVID-19: Adaptation to low transmission settings
por: Lau, Jillian SY., et al.
Publicado: (2021)

HIV cure research in the time of COVID-19 - Antiretroviral therapy treatment interruption trials: A discussion paper
por: Fidler, S., et al.
Publicado: (2020)

Antiretroviral therapy interruptions: impact on HIV treatment and transmission
por: Dubrocq, Gueorgui, et al.
Publicado: (2018)

1568. Implementation of a Standard Diet Regimen for Neutropenic High-Risk Cancer Patients: Effects on Incidence of Infections, Foodborne Diseases, and Outcome
por: Jakob, Carolin, et al.
Publicado: (2018)

Treatment modification after starting cART in people living with HIV: retrospective analysis of the German ClinSurv HIV Cohort 2005–2017
por: Stecher, Melanie, et al.
Publicado: (2020)

HIV/Hepatitis C Virus Co-infection among Adults Beginning Antiretroviral Therapy, Malawi
por: Demir, Münevver, et al.
Publicado: (2016)

Correction to: Treatment modifcation after starting cART in people living with HIV: retrospective analysis of the German ClinSurv HIV Cohort 2005–2017
por: Stecher, Melanie, et al.
Publicado: (2021)

Acceptability, motivation and the prospect of cure for people living with HIV and their healthcare providers in HIV cure-focused treatment interruption studies
por: Lau, Jillian S. Y., et al.
Publicado: (2020)

1767 : una novela sobre el destierro de los jesuitas mexicanos /
por: Soler Frost, Pablo, 1965-
Publicado: (2004)

Recruitment and ethical considerations in HIV cure trials requiring treatment interruption
por: Arnold, Michael P, et al.
Publicado: (2015)

Plasma interferon-γ-inducible protein 10 (IP-10) levels correlate with disease severity and paradoxical reactions in extrapulmonary tuberculosis
por: Suárez, Isabelle, et al.
Publicado: (2020)

Preventing Antiretroviral Treatment Interruptions among HIV/AIDS Patients in Africa
por: Mills, Edward J., et al.
Publicado: (2013)

Prevalence of ABCC3‐1767G/A polymorphism among patients with antiretroviral‐associated hepatotoxicity
por: Singh, HariOm, et al.
Publicado: (2020)

The ethical case for placebo control in HIV-cure-related studies with ART interruption
por: Magalhaes, Monica, et al.
Publicado: (2022)

Oxford weather and climate since 1767
por: Burt, Stephen, et al.
Publicado: (2019)

Adherence to Antiretroviral Therapy and Acceptability of Planned Treatment Interruptions in HIV-Infected Children
por: Harrison, Linda, et al.
Publicado: (2012)

Compartmentalized HIV rebound in the central nervous system after interruption of antiretroviral therapy
por: Gianella, Sara, et al.
Publicado: (2016)

Thymic Output and CD4 T-Cell Reconstitution in HIV-Infected Children on Early and Interrupted Antiretroviral Treatment: Evidence from the Children with HIV Early Antiretroviral Therapy Trial
por: Lewis, Joanna, et al.
Publicado: (2017)

From pills to patients: an evaluation of data sources to determine the number of people living with HIV who are receiving antiretroviral therapy in Germany
por: Schmidt, Daniel, et al.
Publicado: (2015)

Antiretroviral treatment, government policy and economy of HIV/AIDS in Brazil: is it time for HIV cure in the country?
por: Benzaken, Adele S., et al.
Publicado: (2019)

Temporal trends of time to antiretroviral treatment initiation, interruption and modification: examination of patients diagnosed with advanced HIV in Australia
por: Wright, Stephen T, et al.
Publicado: (2015)

Acceptance and tolerability of an adjuvanted nH1N1 vaccine in HIV-infected patients in the Cologne-Bonn cohort
por: Steffens, B, et al.
Publicado: (2011)

Dynamics and durability of HIV-1 neutralization are determined by viral replication
por: Schommers, Philipp, et al.
Publicado: (2023)

Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk/benefit assessment
por: Henderson, Gail E, et al.
Publicado: (2018)

Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infection
por: Gisslén, Magnus, et al.
Publicado: (2005)

Impact of HLA Class I Alleles on Timing of HIV Rebound After Antiretroviral Treatment Interruption
por: Park, You Jeong, et al.
Publicado: (2017)

Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection
por: Colby, Donn, et al.
Publicado: (2018)

HIV Cure Strategies: How Good Must They Be to Improve on Current Antiretroviral Therapy?
por: Sax, Paul E., et al.
Publicado: (2014)

Plasmacytoid Dendritic Cells Accumulate and Secrete Interferon Alpha in Lymph Nodes of HIV-1 Patients
por: Lehmann, Clara, et al.
Publicado: (2010)

413. Intravenous and Tablet Formulation of Posaconazole in Antifungal Therapy and Prophylaxis: A Retrospective, Non-Interventional, Multicenter Analysis of Patients Treated in German Tertiary-Care Hospitals
por: Heimann, Sebastian M, et al.
Publicado: (2018)

580. Key Factors for Treatment Changes Within 1 Year After Starting ART in the German ClinSurv Cohort: Between 2005 and 2014
por: Stecher, Melanie, et al.
Publicado: (2018)

Safety and anti-viral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals
por: Bar-On, Yotam, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_i0eup3rgo5jej3qu7on5kn367a